Supported by an educational grant from Axsome Therapeutics, Inc.

News

Pharmacogenomic Test Improves MDD Response and Remission Outcomes

Clinician use of a specific weighted multigene pharmacogenomic (PGx) test significantly improved outcomes in adult patients with

All News

New Study Finds Quetiapine More Effective Than Lithium in Reducing Treatment-Resistant Depression Symptoms

Quetiapine may be more clinically effective than lithium as an augmentation option for reducing symptoms of treatment-resistant depression (TRD), a type of

Dietary Intervention May Alleviate Symptoms of Depression

Adhering to specific dietary patterns, including the Mediterranean diet, may reduce symptoms of

Accelerated Theta-Burst Stimulation Protocol Improves Treatment-Resistant Depression

A novel 78-minute accelerated theta-burst stimulation (aTBS) protocol reduced depression severity in patients with treatment-resistant depression (TRD), according to resu

Genetic Predispositions to Insomnia, Neuroticism, Linked With Higher Risk for Treatment-Resistant Depression

A genetic predisposition to traits related to neuroticism, cognitive function, and sleep patterns were significantly associated with the development of treatment-resistan